CervoMed (CRVO) Shares Outstanding (2010 - 2026)
CervoMed (CRVO) posted Shares Outstanding (Entity) of $9.3 million for Q1 2026, little changed sequentially from $9.3 million in Q4 2025, and up 6.39% YoY from $8.7 million in Q1 2025.
CervoMed (CRVO) Shares Outstanding (2010 - 2026) Analysis & Trends
CervoMed has reported Shares Outstanding (Entity) for 17 years, with the latest figure at $9.3 million in Q1 2026.
- Quarterly Shares Outstanding (Entity) rose 6.39% year-over-year to $9.3 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $9.3 million (up 6.39% YoY) and the FY2025 annual result came in at $9.3 million, up 6.32% from the prior year.
- Shares Outstanding (Entity) steadied at $9.3 million in Q1 2026 per CRVO's latest filing, from $9.3 million in the prior quarter.
- Over five years, Shares Outstanding (Entity) peaked at $9.3 million in Q1 2026 and troughed at $518140.0 in Q4 2022.
- A 5-year average of $5.3 million and a median of $6.2 million in 2024 frame the typical range for Shares Outstanding (Entity).
- The sharpest annual moves came in 2022 and 2024: Shares Outstanding (Entity) gained 0.05% in 2022, then jumped 506.8% in 2024.
- Over 5 years, Shares Outstanding (Entity) stood at $518140.0 in 2022, then jumped by 413.65% to $2.7 million in 2023, then soared by 227.0% to $8.7 million in 2024, then grew by 6.32% to $9.3 million in 2025, then increased by 0.06% to $9.3 million in 2026.
- According to Business Quant data, Shares Outstanding (Entity) over the past three periods registered $9.3 million, $9.3 million, and $9.3 million for Q1 2026, Q4 2025, and Q3 2025 respectively.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Shares Outstanding (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.13 Bn | 131.28 Bn | 2.84 Bn | 253.70 Mn |
| 2 | Regeneron Pharmaceuticals | 85.77 Bn | 77.77 Bn | 3.93 Bn | 102.80 Mn |
| 3 | Argenx Se | 64.64 Bn | 59.46 Bn | 1.37 Bn | 62.19 Mn |
| 4 | Moderna | 58.29 Bn | 53.16 Bn | 52.00 Mn | 398.00 Mn |
| 5 | BeOne Medicines | 41.92 Bn | 36.82 Bn | 1.53 Bn | 111.58 Mn |
| 6 | Alnylam Pharmaceuticals | 31.58 Bn | 28.28 Bn | 992.69 Mn | 133.61 Mn |
| 7 | BioNTech SE | 28.12 Bn | 9.73 Bn | 668.28 Mn | 241.70 Mn |
| 8 | Insmed | 27.39 Bn | 26.22 Bn | 358.27 Mn | 217.35 Mn |
| 9 | Royalty Pharma | 27.27 Bn | 26.43 Bn | - | 445.06 Mn |
| 10 | CervoMed | 26.64 Mn | 26.64 Mn | - | 10.24 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 10.24 Mn |
| Mar 31, 2026 | 9.26 Mn |
| Dec 31, 2025 | 9.04 Mn |
| Sep 30, 2025 | 9.25 Mn |
| Jun 30, 2025 | 8.95 Mn |
| Mar 31, 2025 | 8.70 Mn |
| Dec 31, 2024 | 8.07 Mn |
| Sep 30, 2024 | 8.70 Mn |
| Jun 30, 2024 | 8.70 Mn |
| Mar 31, 2024 | 6.17 Mn |
| Dec 31, 2023 | 2.66 Mn |
| Sep 30, 2023 | 3.31 Mn |
| Jun 30, 2023 | 1.36 Mn |
| Mar 31, 2023 | 1.36 Mn |
| Dec 31, 2022 | 518,140.00 |
| Sep 30, 2022 | 1.36 Mn |
| Jun 30, 2022 | 1.36 Mn |
| Mar 31, 2022 | 1.36 Mn |
| Dec 31, 2021 | 138,683.00 |
| Sep 30, 2021 | 1.36 Mn |